Your browser doesn't support javascript.
Could Curcumin hydrogel for photodynamic therapy fight against SARS-CoV-2?
Biointerface Research in Applied Chemistry ; 13(2), 2023.
Article in English | Scopus | ID: covidwho-1791299
ABSTRACT
A traditional Chinese medicineCurcumin” has been used as a photosensitizer in the application of photodynamic therapy such a long time. However, it has significant limitations, including poor “solubility” and “absorbtivity”. “Hydrogel” is being used to overcome these problems, which enhance the biodegradability and biocompatibility of curcumin. This present article discusses the background, research progress, and clinical study to describe the possibility of curcumin hydrogel for photodynamic therapy fight against SARS-CoV-2. Based on the literature review finding, curcumin as a photosensitizer uses a microcatheter to incorporate the hydrogel systemically or locally into the lungs through the pulmonary artery to combat SARS-CoV-2. It is extracorporeal illumination for photodynamic therapy, which exposure to blue light with a mean wavelength of 450 nm is a much safe and limited depth of photodynamic therapy treatment. Thus, curcumin incorporated with the hydrogel is a suitable candidate used for the photodynamic treatment of SARS-CoV-2, cancer, wound healing, and bacterial infection. © 2022 by the authors.
Keywords

Full text: Available Collection: Databases of international organizations Database: Scopus Language: English Journal: Biointerface Research in Applied Chemistry Year: 2023 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: Databases of international organizations Database: Scopus Language: English Journal: Biointerface Research in Applied Chemistry Year: 2023 Document Type: Article